PubMed

The Future of Smallpox Vaccination: is MVA the key?

Slifka MK.

Med Immunol. 2005 Mar 1;4(1):2.PMID: 15740619 [PubMed - as supplied by publisher]Related articlesFree article

Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Meseda CA, Garcia AD, Kumar A, Mayer AE, Manischewitz J, King LR, Golding H, Merchlinsky M, Weir JP.

Virology. 2005 Sep 1;339(2):164-75.PMID: 15993917 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.

Phelps AL, Gates AJ, Hillier M, Eastaugh L, Ulaeto DO.

Vaccine. 2007 Jan 2;25(1):34-42. Epub 2006 Aug 1.PMID: 16950548 [PubMed - indexed for MEDLINE]Related articles

Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.

Earl PL, Americo JL, Wyatt LS, Espenshade O, Bassler J, Gong K, Lin S, Peters E, Rhodes L Jr, Spano YE, Silvera PM, Moss B.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10889-94. Epub 2008 Aug 4.PMID: 18678911 [PubMed - indexed for MEDLINE]Related articlesFree article

Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.

Ferrier-Rembert A, Drillien R, Tournier JN, Garin D, Crance JM.

Vaccine. 2008 Mar 25;26(14):1794-804. Epub 2008 Feb 12.PMID: 18336966 [PubMed - indexed for MEDLINE]Related articles

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh SK.

J Virol. 2007 Aug;81(16):8774-83. Epub 2007 Jun 6.PMID: 17553867 [PubMed - indexed for MEDLINE]Related articlesFree article

Smallpox: the basics.

Slifka MK, Hanifin JM.

Dermatol Clin. 2004 Jul;22(3):263-74, vi. Review.PMID: 15207308 [PubMed - indexed for MEDLINE]Related articles

Smallpox vaccine: the good, the bad, and the ugly.

Belongia EA, Naleway AL.

Clin Med Res. 2003 Apr;1(2):87-92. Review.PMID: 15931293 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

Cosma A, Nagaraj R, Staib C, Diemer C, Wopfner F, Schätzl H, Busch DH, Sutter G, Goebel FD, Erfle V.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):782-93.PMID: 17604541 [PubMed - indexed for MEDLINE]Related articles

The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.

Coulibaly S, Brühl P, Mayrhofer J, Schmid K, Gerencer M, Falkner FG.

Virology. 2005 Oct 10;341(1):91-101.PMID: 16061267 [PubMed - indexed for MEDLINE]Related articles

Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.

Davies DH, Wyatt LS, Newman FK, Earl PL, Chun S, Hernandez JE, Molina DM, Hirst S, Moss B, Frey SE, Felgner PL.

J Virol. 2008 Jan;82(2):652-63. Epub 2007 Oct 31.PMID: 17977963 [PubMed - indexed for MEDLINE]Related articlesFree article

Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.

Paran N, Suezer Y, Lustig S, Israely T, Schwantes A, Melamed S, Katz L, Preuss T, Hanschmann KM, Kalinke U, Erez N, Levin R, Velan B, Löwer J, Shafferman A, Sutter G.

J Infect Dis. 2009 Jan 1;199(1):39-48.PMID: 19012492 [PubMed - indexed for MEDLINE]Related articles

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals.

Parrino J, McCurdy LH, Larkin BD, Gordon IJ, Rucker SE, Enama ME, Koup RA, Roederer M, Bailer RT, Moodie Z, Gu L, Yan L, Graham BS; VRC 201/203 Study Team.

Vaccine. 2007 Feb 9;25(8):1513-25. Epub 2006 Nov 7.PMID: 17126963 [PubMed - indexed for MEDLINE]Related articlesFree article

[Utilization of the MVA-immunization schedule from the view point of the public health service]

Weber HG.

Fortschr Med. 1977 Jun 2;95(21):1381-6. German. PMID: 17567 [PubMed - indexed for MEDLINE]Related articles

Smallpox vaccines: Past, present, and future.

Parrino J, Graham BS.

J Allergy Clin Immunol. 2006 Dec;118(6):1320-6. Review.PMID: 17157663 [PubMed - indexed for MEDLINE]Related articles

Bioterrorism and smallpox planning: information and voluntary vaccination.

Selgelid MJ.

J Med Ethics. 2004 Dec;30(6):558-60.PMID: 15574444 [PubMed - indexed for MEDLINE]Related articlesFree article

IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.

Kennedy JS, Greenberg RN.

Expert Rev Vaccines. 2009 Jan;8(1):13-24. Review.PMID: 19093767 [PubMed - indexed for MEDLINE]Related articles

Vaccinia immune globulin: current policies, preparedness, and product safety and efficacy.

Wittek R.

Int J Infect Dis. 2006 May;10(3):193-201. Epub 2006 Mar 27. Review.PMID: 16564720 [PubMed - indexed for MEDLINE]Related articles

Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.

García AD, Meseda CA, Mayer AE, Kumar A, Merchlinsky M, Weir JP.

Clin Vaccine Immunol. 2007 Aug;14(8):1032-44. Epub 2007 Jun 27.PMID: 17596428 [PubMed - indexed for MEDLINE]Related articlesFree article

Smallpox vaccines for biodefense: need and feasibility.

Artenstein AW, Grabenstein JD.

Expert Rev Vaccines. 2008 Oct;7(8):1225-37. Review.PMID: 18844596 [PubMed - indexed for MEDLINE]Related articles